the Multi-modal Evaluation of Agitation in Critically Ill Patients Based on Remote Video-Ultra-sensitive Detection Wave
A Multi-modal Recognition Model and Efficacy Evaluation for Agitation Behavior in Critically Ill Patients Based on Remote -Ultra-sensitive Detection Wave ---A Multi-center, Open-label, Observational Study
Second Affiliated Hospital, School of Medicine, Zhejiang University
580 participants
May 1, 2024
OBSERVATIONAL
Conditions
Summary
The goal of this observational study is to learn about the effectiveness of the multi-modal evaluation for agitation behavior in critically ill patients based on remote video-Ultra-sensitive detection wave. The main question it aims to answer is: evaluate the effectiveness of multi-modal evaluation monitoring system for agitated critically ill patients Participants already taking multi-modal evaluation monitoring system as part of their regular medical care for agitated critically ill patients will compare their effectiveness for agitation for 3 years.
Eligibility
Inclusion Criteria3
- Patients at risk of agitation in the ICU
- Patients with RASS score -2 and above
- ≦ 65 years old, ≧ 18 years old
Exclusion Criteria11
- The affected party refused to participate in this study
- Missing/incomplete information
- Vulnerable groups such as pregnant women, those who lack the capacity for civil conduct and do not have the consent of their legal representatives
- Maxillofacial trauma, burns, tumors, surgery, etc. affect facial expression
- Patients with limb impairment and amputation
- Spinal cord injury, limb movement/sensory limitations
- Patients with pre-existing neurological/psychiatric diseases
- Patients with malignant tumors
- Patients with infectious diseases
- Patients with terminal disease and dying disease
- Abnormal behavior due to head injury or craniocerebral disease
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
All agitated critically illed patients are monitored by manual and multi-model monitoring and alert system
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06543602